Lufax updates HKEX resumption progress as share trading stays suspended

Lufax Holding Ltd furnished a Form 6-K attaching a Hong Kong Stock Exchange announcement on modified resumption guidance, additional independent-investigation and internal-control findings, and continued suspension of trading in its ordinary shares on HKEX.

Lufax is still working through Hong Kong listing-resumption conditions more than a year and a half after its shares were halted, and today’s update keeps the suspension in place.

What the 6-K carries

On September 21, 2026, Lufax Holding Ltd (NYSE: LU; HKEX: 6623) filed a Form 6-K whose Exhibit 99.1 is an HKEX announcement titled “(1) Modified Resumption Guidance; (2) Additional Details on the Key Findings of Independent Investigation and Supplemental Investigation; (3) Key Findings and Results of Internal Control Review; and (4) Continued Suspension of Trading.”

Modified guidance and deadline context

The company says that on April 24, 2026 it received a Stock Exchange letter amending resumption guidance so the required independent forensic investigation covers (i) the Subject Transactions, (ii) Loan Transactions (to identify similar entities/transactions), and (iii) hospitality expenses incurred by certain employees that had not previously been consolidated into Lufax’s financial records, plus assessment of operational/financial impact, public findings, and remedial actions.

The announcement restates that under Listing Rule 6.01A(1) the Exchange may cancel the listing if shares are suspended for 18 continuous months and the company fails to remedy issues and resume by the end of that period (stated as July 27, 2026), and that Rules 6.01 and 6.10 also allow a shorter remedial period or immediate cancellation.

Progress claimed

Lufax says it appointed Morgan, Lewis & Bockius LLP with AlixPartners forensic support for independent investigations; restated FY2022–2023 financials with Ernst & Young as successor auditors and published outstanding results (including FY2022–2024 annual information published February 15, 2026 and 2025 interim/audited annual results on April 30, 2026); optimized Board/management structure and created a Chief Compliance Officer role; and appointed Deloitte Consulting (Shanghai) for an internal-control review whose follow-up, per the company, found recommended improvements adopted and implemented.

Trading status

At the company’s request, trading in ordinary shares on The Stock Exchange of Hong Kong Limited has been halted since 9:00 a.m. on January 28, 2025, and “will remain suspended,” the announcement concludes, advising shareholders and potential investors to exercise caution.